China Resources Jiangzhong Pharmaceutical Co.,Ltd (600750.SS) has a MoatMap StockRank of 89/100 based on Quality (76/100), Value (47/100), and Momentum (52/100) factor scores. The current signal is STRONG BUY. China Resources Jiangzhong is a high-quality traditional Chinese medicine manufacturer. However, it operates as a domestic consumer healthcare play rather than a CDMO, meaning it does not benefit from the CDMO pricing power cycle or other active macro themes.
China Resources Jiangzhong Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company specializing in over-the-counter (OTC) digestive medicines and health supplements. The company possesses a powerful competitive moat in its household brand names, 'Jiangzhong' and 'Jianwei Xiaoshi Tablets,' which command dominant market shares in the digestive health segment. Backed by the massive China Resources Group, it leverages an extensive national distribution network and strong retail pharmacy relationships.
| Price | $3.72 |
| Market Cap | $2.4B |
| P/E (TTM) | 18.03 |
| P/E (Forward) | 17.31 |
| Price/Book | 3.77 |
| Return on Equity | 20.3% |
| Return on Invested Capital | 24.4% |
| Debt/Equity | 0.04 |
| Gross Margin | 65.3% |
| Operating Margin | 32.0% |
| Revenue Growth | -12.5% |
| Dividend Yield | 4.7% |
| Free Cash Flow | $-6M |
China Resources Jiangzhong Pharmaceutical Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).